Tenaya therapeutics to participate at the 42nd annual j.p. morgan healthcare conference

South san francisco, calif., jan. 03, 2024 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that faraz ali, chief executive officer, will present at the 42nd annual j.p. morgan healthcare conference on january 11, 2024, at 9:45 am pt.
TNYA Ratings Summary
TNYA Quant Ranking